Genetech Inc said still remains confident able work U.S. Food Drug Adminstration obtain approval tissue plasminogen activator Activase use treating heart attack victim .
On Friday advisory committee FDA recommended blood clot dissolving drug approved additional mortality data developed .
Genetech said provide additional data belief much already developed .
Reuter & # 3 ; 